期刊
TOXICOLOGY LETTERS
卷 350, 期 -, 页码 194-201出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2021.07.011
关键词
Enzyme inhibition; HSA; Organophosphorus compound; Phosphotriesterase; Zinc
类别
资金
- Bundesamt fur Ausrustung, Informationstechnik und Nutzung der Bundeswehr (Germany) [E/U2AD/GD003/GF560]
The phosphotriesterase BdTPE is inhibited by human plasma components, particularly serum albumin, which depletes crucial zinc ions from the enzyme's active site. The concentration of available zinc ions in blood plays a significant role in BdTPE activity in vivo.
The phosphotriesterase of the bacterium Brevundimonas diminuta (BdPTE) is a naturally occurring enzyme that catalyzes the hydrolysis of organophosphate (OP) nerve agents as well as pesticides and offers a potential treatment of corresponding intoxications. While BdPTE mutants with improved catalytic efficiencies against several OPs have been described, unexpectedly, less efficient breakdown of an OP was observed upon application in an animal model compared with in vitro measurements. Here, we describe detailed inhibition studies with the high-activity BdPTE mutant 10-2C3(C59M/C227A) by human plasma components, indicating that this enzyme is inhibited by serum albumin. The inhibitory activity is mediated by depletion of crucial zinc ions from the BdPTE active site, either via the known high-affinity zinc binding site of albumin or via chemical complex formation with its free thiol side chain at position Cys34. Albumin pre-charged with zinc ions or carrying a chemically blocked Cys34 side chain showed significantly reduced inhibitory activity; in fact, the combination of both measures completely abolished BdPTE inhibition. Consequently, the available zinc ion concentration in blood plays an important role for BdPTE activity in vivo and should be taken into account for therapeutic development and application of a catalytic OP scavenger. (c) 2021 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据